Srinivasan Kellathur is currently the Roche Pharma Technical Regulatory Policy Lead for APAC, based in Singapore. At Roche, he drives regulatory convergence initiatives with a focus on CMC and ensures the implementation of reliance pathways across the region.
Prior to joining Roche, Srini was with the Health Sciences Authority, Singapore heading the Advanced Therapy Products Branch and implemented the cell, tissue, and gene therapy products regulations in 2021, the first country to implement in ASEAN. In addition, to promote and advance prospective regulatory convergence efforts, he is representing the BIO as a sub-champion for advanced therapy products priority work area established under the auspices of Asia Pacific Economic Cooperation.
Srini also an adjunct assistant professor at the Centre of Regulatory Excellence, Duke–NUS Medical School.
